Before You Buy Linde Stock, Settle This
Linde (LIN) is restructuring its Lincare division, which has reduced its 2026 EPS growth by 1.5% to 2%. Management expects to return to double-digit EPS growth once Lincare's issues are resolved. Linde guided 8% to 9% EPS growth for 2026, with Q4 growth expected at 5% to 7%. The company took a $425M restructuring charge in Q3, with benefits expected from Q4 and fully realized by mid-2027.
How this was made
The 30-second read
Why it matters
The guidance suggests limited near‑term upside, keeping the stock near current valuation levels.
Market read
Linde's modest guidance may keep the stock flat, with limited broader market effect.
What to watch
Potential cost synergies from the $425 million restructuring charge may materialize later in 2027.
Background
The article recaps Linde's third‑quarter 2026 earnings call, focusing on the Lincare unit's impact and FY guidance.
Ticker impact
Linde disclosed Q3 2026 call details and FY 2026 EPS guidance, noting a 2% earnings drag from Lincare and an 8‑9% growth target.
likely slight downside as investors price in the cautious EPS outlook
The guidance does not improve on prior expectations and emphasizes a drag from Lincare, limiting upside.
Market effects
Industrial gases sector may see modest sentiment as Linde signals slower growth.
European industrial gas markets could be mildly affected by Linde's guidance.
Limited; the news is company‑specific without broader macro impact.
Counterpoint
If Lincare restructuring succeeds faster than expected, the EPS drag could disappear, offering upside.
Key entities
- CompanyLinde plc
Global industrial gases producer (ticker LIN).
